|
Indian Pediatr 2012;49:
100-101 |
|
Low Serum Magnesium and Obesity – Causal Role
or Diet Biomarker?
|
Anura V Kurpad And Isabelle Aeberli
Division of Nutrition, St John’s Research Institute,
Bangalore 560034, India.
Email: [email protected]
|
The association between a low
magnesium (Mg) status, and insulin resistance and the metabolic syndrome
has been shown repeatedly in adults [1], and higher Mg intakes have been
shown to have a protective role [2]. This leads to the tantalizing
conclusion of a mechanistic involvement of Mg in weight gain and insulin
resistance through its critical role as a co-factor in several enzymes
in carbohydrate metabolism [1]. However, the Km
of Mg for these enzymes is close to its intracellular concentration,
which does not decline easily on Mg deficient diets [3]. The effect is
also subtle: the adjusted risk for diabetes with quite low (<1.7 mg/dL)
serum Mg levels have been shown to increase modestly by about 1.5 fold
[4]. Furthermore, reverse causality is also possible: diabetes is known
to increase renal Mg excretion, and insulin resistance decreases Mg
uptake. Therefore, the theoretical framework that links low Mg status to
obesity and insulin resistance is not simple.
The relation between obesity and Mg is also not
clear. Several studies have assessed the association between body mass
index and Mg intake or status in adults, but the results are still
controversial [2,5]. This may be because the associations of low serum
Mg with obesity related outcomes are subtle and subject to type 2
errors. In this issue of Indian Pediatrics, Jose, et al.
[6] have found that serum Mg was lower in obese Indian children, but
this counter-intuitively occurred with apparently higher Mg intakes. The
authors are careful not to imply any mechanistic linkage either way, but
speculate that the aggravation of the insulin resistant state with low
serum Mg could start early in childhood.
Measuring Mg status accurately is challenging, since
serum Mg is only about 1% of the total body Mg, and most probably
reflects its renal handling rather than its dietary intake. A very low
Mg diet (<10%) in a human subject in ‘excellent health’ led to a drop by
about 0.4 mg/dL in serum levels, along with negative balances, but no
drop in intracellular levels [3]. On the other hand, intracellular Mg
depletion has been found with normal serum Mg concentrations [1]. The
point is that Mg intake cannot easily be related to serum level or
status. Pre-analytical factors, including the effect of prior exercise
on serum Mg, are also important.
Nevertheless, given the observation that the obese
children had a higher energy adjusted Mg intake [6], the low serum Mg
levels are likely to be an ‘effect’ rather than a cause. The authors’
opinion is that the observed differences could have been due to
decreased Mg absorption or increased excretion. Both these mechanisms
are plausible. The questions relate to how and why. For example, one
could enquire whether the obese children had a higher calcium (Ca)
intake, since this is known to interfere with Mg absorption. Indeed,
dairy products are high in Ca and low in Mg content. The intake of
carbonated soft drinks, with higher intakes of phosphorus could also
interfere with absorption while caffeine can increase renal Mg excretion
[7]. A vegetarian and unprocessed food-based diet, such as with whole
grains, nuts, and green leafy vegetables, is high in Mg, which is lost
during processing. Therefore, in studies that investigate associations
between serum Mg and other outcomes, it is critical to have a close
inspection of the dietary environment.
Observational studies such as those by Jose, et
al. [6] are important in a transitioning society with changing
processed food intake; however, longitudinal studies with detailed food
intake assessment are required to assign causality or to assess the
potential interaction with insulin resistance. Until then, the role of
Mg will remain enigmatic, the need for supplements unclear, and serum Mg
may simply have to continue to be considered as a biomarker for a
particular type of diet.
Competing interests: Dr Kurpad is a member of the
Kraft Health and Wellness Global Advisory Board; Funding: None.
References
1. Barbagallo M, Dominguez LJ. Magnesium metabolism
in type 2 diabetes mellitus, metabolic syndrome and insulin resistance.
Arch Biochem Biophys. 2007;458:40-7.
2. He K, Liu K, Daviglus ML, Morris SJ, Loria CM, Van
Horn L, et al. Magnesium intake and incidence of metabolic
syndrome among young adults. Circulation. 2006;113:1675-82.
3. Dunn MJ, Walser M. Magnesium depletion in normal
man. Metabolism. 1966;15:884-95.
4. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL,
Brancati FL. Serum and dietary magnesium and the risk for type 2
diabetes mellitus: The Atherosclerosis Risk in Communities Study. Arch
Intern Med. 1999;159:2151-9.
5. Song Y, Sesso HD, Manson JE, Cook NR, Buring JE,
Liu S. Dietary magnesium intake and risk of incident hypertension among
middle-aged and older US women in a 10-year follow-up study. Am J
Cardiol. 2006;98:1616-21.
6. Jose B, Jain V, Vikram NK, Agarwala A, Saini S.
Serum magnesium in overweight children. Indian Pediatr. 2012, 49:109-12.
7. Swaminathan R. Magnesium metabolism and its disorders. Clin
Biochem Rev. 2003;24:47-66.
|
|
|
|